Eltromag 50mg Tablet

Chronic idiopathic thrombocytopenia

Treatment of Severe Aplastic Anemia

Low platelet count due to ITP or HCV infection

The human body reacts differently to Eltromag 50mg Tablet. Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine; these side effects don't need special medical attention. Whereas if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately. Some of the common side effects of Eltromag 50mg Tablet are mentioned below: Cold
Fever
Hair loss
Diarrhea
Back pain
Joint pain
Headache
Muscle pain
Loss of appetite
Abdominal pain
Nausea & Vomiting
Urinary tract infection
Mouth and throat pain
Swelling in feet or hands
Increased level of liver enzymes
Upper respiratory tract infection

Take the dose of Eltromag 50mg Tablet as per your healthcare provider’s prescription. Do not stop taking the medicine suddenly, unless your doctor tells you. This medicine is given under the strict supervision of a doctor. Do not self-administer. Overdose is a very unusual state for this medicine because it is given under the supervision of a healthcare provider. Eltromag 50mg Tablet can be taken without food or with food. The doctor will provide emergency medical treatment. You should not break, crush, or chew the medicine; it should be swallowed as a whole.

Eltromag 50mg Tablet helps to prevent or reduce bleeding by stimulating the formation of new platelets in the blood. It is a thrombopoietin (TPO) receptor agonist, which binds and activates the TPO receptor on megakaryocytes and, as a result, increases platelet production in the blood.

It is advised not to miss any scheduled dosage of Eltromag 50mg Tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.

It is advised to use effective birth control ways and avoid pregnancy during the treatment with Eltromag Tablet.
A person should avoid smoking while undergoing treatment with Eltromag. Smoking may reduce the effectiveness of medicine.
Monitor your blood sugar & pressure, Kidney & Liver function (KFT & LFT), and Heart function at proper intervals after taking Eltromag Tablet.
Skin becomes extremely sensitive after taking Eltromag. It is advised to cover your skin exposed to direct sun rays and use high SPF sunscreen before going out.
It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Eltromag Tablet, as it may reduce the effectiveness of the medicine.
Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking an Eltromag Tablet. Consult your doctor if it doesn't stop or if blood appears in your stools.
In case you notice symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Eltromag, consult your doctor immediately before these symptoms become severe.

Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, Parikh AR, Soto S, Biancotto A, Feng X, Lozier J, Wu CO, Young NS, Dunbar CE. (2023). Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 367(1):11-9.

Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, Parikh AR, Broder K, Calvo KR, Wu CO, Young NS, Dunbar CE. (2025). Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of the drug. Blood. 123(12):1818-25.

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med. 376(16):1540-1550.

Scheinberg P. (2023). Activity of eltrombopag in severe aplastic anemia. Blood Adv. 2(21):3054-3062.

Elgebaly AS, Ashal GE, Elfil M, Menshawy A. (2024). Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials. Clinical
and Applied Thrombosis/Hemostasis. 23(8):928-937.

Zhuang T, Wang S, Yu X, He X, Guo H, Ou C. (2025). Current status and future perspectives of platelet-derived extracellular vesicles in cancer diagnosis and treatment. Biomark Res 12(1):88.